N/A
N=162
Randomized Contralateral Clinical Trial With Single-piece (SN60WF) vs. Three Piece (MA60AC) AcrySof Intraocular Lenses (IOLs) on Development of Posterior Chamber Opacification (PCO).
Cataract
Bottom Line
View on ClinicalTrials.gov: NCT00758745 ↗Enrolled (actual)
162
Serious AEs
0.0%
Results posted
Jul 2011
Primary outcome: Primary: Posterior Capsule Opacification (PCO) — 0.18; 0.15 Units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Model SN60WF (Device); Model MA60AC (Device)
- Age
- Adult, Older Adult · 50+ yrs
- Sex
- All
- Sponsor
- Alcon Research
- Primary completion
- Dec 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Posterior Capsule Opacification (PCO) |
0.18; 0.15 | — |
Summary
Randomized contralateral clinical trial with single piece (Model SN60WF) vs. three piece (Model MA60AC) AcrySof Intraocular Lenses (IOLs) on development of Posterior Chamber Opacifiation (PCO).
Eligibility Criteria
Inclusion Criteria
- Age > 50 years
- Clear cornea
- Pupil mydriasis ≥ 7mm
- In the bag Intraocular Lens (IOL)
Exclusion Criteria
- Ocular pathology - uveitis, glaucoma, pseudoexfoliation syndrome (PEX), high myopia
- Previously operated eye
- Proliferative diabetic retinopathy
- Surgical complications - incomplete rhexis, post capsular rupture (PCR), zonular dialysis
Data sourced from ClinicalTrials.gov (NCT00758745). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.